P248 Evaluation of potential factors related to chemotherapy-induced nausea and vomiting (CINV) among Chinese breast cancer patients: individual patient data analysis
Main Authors: | W. Yeo, H. Yeo, K. Lai, E. Pang, F. Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623003661 |
Similar Items
-
Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
by: Rashad N, et al.
Published: (2017-03-01) -
Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
by: Ai Gao, et al.
Published: (2023-07-01) -
Gambaran Skor INVR (Index of Nausea, Vomiting and Retching) pada CINV (Chemotherapy Induced Nausea and Vomiting) Kanker Payudara di RSUP M Djamil Padang
by: Wella Juartika, et al.
Published: (2020-01-01) -
Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.
by: Giovanna Giagnuolo, et al.
Published: (2019-01-01) -
Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
by: Yeo W, et al.
Published: (2024-04-01)